ETNI:Entest Group Inc - Stock Quote and Dividend Data
LATEST CLOSE PRICE
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Payment TypeReverse Split
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone
52-Week Low/High$0.01 - $0.09
Percent Held by Institutions0.00%
PE Ratio to Industry66%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-51.31%
Total Return Last 3 Years71.82%
Total Return Last 5 Years-74.80%
Latest Trade DateDec. 11, 2018
No Data available for Payment History.
Entest Group engages in the development and commercialization of immunotherapeutic therapies for the veterinary market as well as the acquisition and operation of veterinary hospitals. Co. is focusing its research and development activities toward the development and commercialization of ImenVaxÂ™, a therapeutic cancer vaccine for use in canines as well as the development and commercialization of certain intellectual property for non-human veterinary therapeutic use licensed to its subsidiary, Zander Therapeutics, Inc. Co.'s products under development include: ImenVaxÂ™ I, a therapeutic for canine cancer and ENT-576Â™ therapy for the treatment of Chronic Obstructive Pulmonary Disease.
SegmentPharmaceuticals & Biotechnology
Dividend AllStar™ Ranking
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dec. 11, 2018CLOSE PRICE DECREASE: Entest Group Inc (OTCBB: ETNI) on 12-11-2018 decreased close price > 10% from $0.02 to $0.01Read more...
Dec. 05, 2018CLOSE PRICE INCREASE: Entest Group Inc (OTCBB: ETNI) on 12-05-2018 increased close price > 10% from $0.02 to $0.02Read more...
Dec. 01, 2018CLOSE PRICE INCREASE: Entest Group Inc (OTCBB: ETNI) on 12-01-2018 increased close price > 10% from $0.01 to $0.01Read more...
Dec. 11, 2018CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-11-2018 increased close price > 10% from $0.04 to $0.05Read more...
Dec. 11, 2018CLOSE PRICE INCREASE: CTD Holdings Inc (FL) (OTCBB: CTDH) on 12-11-2018 increased close price > 10% from $0.82 to $0.95Read more...
Dec. 11, 2018CLOSE PRICE DECREASE: ChromaDex Corp (NASDAQ: CDXC) on 12-11-2018 decreased close price > 10% from $3.17 to $2.85Read more...